Mif
M. musculus
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
What the model saw
Gene: Mif Organism: Mus musculus Known functions: macrophage migration inhibitory factor (glycosylation-inhibiting factor). macrophage migration inhibitory factor. chemoattractant activity. cytokine activity. cytokine receptor binding. dopachrome isomerase activity. identical protein binding. phenylpyruvate tautomerase activity. protease binding. protein-containing complex binding.
View unredacted entry
macrophage migration inhibitory factor (glycosylation-inhibiting factor). macrophage migration inhibitory factor. chemoattractant activity. cytokine activity. cytokine receptor binding. dopachrome isomerase activity. identical protein binding. phenylpyruvate tautomerase activity. protease binding. protein-containing complex binding.
Solver output
MIF (Macrophage Migration Inhibitory Factor) is a pleiotropic pro-inflammatory cytokine that promotes macrophage activation, immune cell recruitment via chemoattractant activity, and sustains inflammatory responses by inhibiting glucocorticoid-mediated immune suppression. Chronic, low-grade inflammation (inflammaging) is a well-established driver of aging and age-related pathology, and MIF is a key upstream mediator of this process. MIF also activates NF-κB and MAPK signaling cascades, amplifying inflammatory cytokine production. Its tautomerase enzymatic activity (phenylpyruvate tautomerase/dopachrome isomerase) is linked to its pro-inflammatory signaling role. Studies in mice show that MIF deficiency is associated with reduced inflammatory burden and improved metabolic profiles, suggesting its normal function accelerates aging-associated pathology rather than opposing it.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model correctly predicted anti_longevity for Mif in Mus musculus. The mechanistic reasoning is sound: MIF is a pro-inflammatory cytokine, and its role in promoting chronic inflammation (inflammaging) as a driver of aging-related pathology is well-established. The model correctly identifies that MIF deficiency in mice is associated with reduced inflammatory burden, supporting the anti-longevity classification. The confidence of 0.75 is appropriate. The reasoning about NF-κB/MAPK signaling, macrophage activation, and inflammaging is accurate and relevant. Minor note: the model could have cited more specific longevity studies in mice, but the overall mechanistic framework is correct.
Raw API responses
solver
{
"reasoning": "MIF (Macrophage Migration Inhibitory Factor) is a pleiotropic pro-inflammatory cytokine that promotes macrophage activation, immune cell recruitment via chemoattractant activity, and sustains inflammatory responses by inhibiting glucocorticoid-mediated immune suppression. Chronic, low-grade inflammation (inflammaging) is a well-established driver of aging and age-related pathology, and MIF is a key upstream mediator of this process. MIF also activates NF-κB and MAPK signaling cascades, amplifying inflammatory cytokine production. Its tautomerase enzymatic activity (phenylpyruvate tautomerase/dopachrome isomerase) is linked to its pro-inflammatory signaling role. Studies in mice show that MIF deficiency is associated with reduced inflammatory burden and improved metabolic profiles, suggesting its normal function accelerates aging-associated pathology rather than opposing it.",
"confidence": 0.75,
"key_pathways": [
"NF-κB/MAPK pro-inflammatory signaling",
"macrophage activation and cytokine cascade",
"inflammaging/chronic sterile inflammation"
],
"mechanism_class": "chronic_inflammation",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model correctly predicted anti_longevity for Mif in Mus musculus. The mechanistic reasoning is sound: MIF is a pro-inflammatory cytokine, and its role in promoting chronic inflammation (inflammaging) as a driver of aging-related pathology is well-established. The model correctly identifies that MIF deficiency in mice is associated with reduced inflammatory burden, supporting the anti-longevity classification. The confidence of 0.75 is appropriate. The reasoning about NF-κB/MAPK signaling, macrophage activation, and inflammaging is accurate and relevant. Minor note: the model could have cited more specific longevity studies in mice, but the overall mechanistic framework is correct.",
"failure_mode": "correct",
"answer_correct": true,
"mechanism_correct": true,
"reasoning_quality": 4,
"ground_truth_questionable": false
}